Y-27632 Dihydrochloride: Selective ROCK1/2 Inhibitor for Cytoskeletal and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a potent, cell-permeable inhibitor of ROCK1 and ROCK2, exhibiting an IC50 of ~140 nM for ROCK1 and Ki of 300 nM for ROCK2 with over 200-fold selectivity against other kinases [APExBIO product data]. It disrupts Rho-mediated stress fiber formation and modulates cell cycle progression from G1 to S phase (De Hoyos et al., 2023). The compound is validated for enhancing stem cell viability and suppressing tumor invasion in vitro and in vivo. Its robust solubility profile and storage stability facilitate reproducible experimental workflows in cytoskeletal, stem cell, and cancer research [see also].

Biological Rationale

The Rho/ROCK pathway is pivotal for regulating actin cytoskeletal dynamics, cell adhesion, and motility. Rho-associated protein kinases (ROCK1 and ROCK2) phosphorylate downstream targets, promoting actomyosin contractility and stress fiber formation in various cell types (De Hoyos et al., 2023). Inhibition of ROCK kinases has become a cornerstone for dissecting cytoskeletal reorganization, cell proliferation, and invasion mechanisms. Modulation of ROCK activity impacts cell cycle progression, cytokinesis, and barrier function, which are critical in cancer, tissue engineering, and neuro-epithelial research. The selective inhibition of ROCK1/2 by Y-27632 dihydrochloride enables precise perturbation of these processes without confounding off-target effects on related kinases [related review].

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride is a small-molecule inhibitor that targets the catalytic domains of ROCK1 and ROCK2. It competitively binds the ATP-binding site, thereby blocking phosphorylation of downstream substrates such as myosin light chain (MLC) and LIM kinase. This inhibition leads to a reduction in actin stress fiber and focal adhesion formation. Quantitatively, the compound exhibits an IC50 of approximately 140 nM for ROCK1 and a Ki of 300 nM for ROCK2, with more than 200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK, and PAK [APExBIO]. As a cell-permeable molecule, Y-27632 rapidly accesses intracellular targets, resulting in acute modulation of Rho-mediated signaling. The functional outcomes include disrupted cytokinesis, altered cell morphology, and reduced migratory/invasive behavior in a range of cell models [see also].

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 activity with an IC50 of ~140 nM under in vitro kinase assay conditions (APExBIO product data: product page).
• Demonstrates over 200-fold selectivity versus PKC, MLCK, and PAK, minimizing off-target effects (APExBIO).
• Disrupts Rho-mediated formation of actin stress fibers in mammalian epithelial and smooth muscle cells (De Hoyos et al., 2023, DOI).
• Reduces proliferation of prostatic smooth muscle cells in a concentration-dependent manner in vitro (APExBIO).
• Suppresses tumor invasion and metastasis in mouse models by diminishing pathological tissue structures (De Hoyos et al., 2023, DOI).
• Enhances viability of human stem cells during routine passaging and expansion (Precision Inhibition Review).
• Retains chemical stability when stored as desiccated solid at ≤4°C or as stock solution at <-20°C for several months (APExBIO).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is extensively applied in cytoskeletal research, stem cell culture, cancer invasion assays, and neuro-epithelial co-culture systems. In gut-on-a-chip models, it facilitates the maintenance and planarization of human intestinal organoid-derived epithelial cells while supporting neuro-epithelial connectivity (De Hoyos et al., 2023). In cancer biology, the inhibitor is a tool for dissecting the role of Rho/ROCK signaling in invasion and metastasis, especially in combination with live imaging and molecular perturbation platforms. Contrasting with this guide, which emphasizes emerging molecular mechanisms, the present article provides up-to-date benchmarks and workflow integration strategies for robust assay design.

Common Pitfalls or Misconceptions

• Y-27632 dihydrochloride does not inhibit all Rho pathway components—its selectivity is restricted to ROCK1 and ROCK2; Cdc42 and Rac pathways remain unaffected.
• Long-term storage of aqueous or DMSO solutions at room temperature leads to degradation; only desiccated solid or stock solutions at <-20°C are stable (APExBIO).
• Not effective for non-ROCK-dependent cytoskeletal phenomena, such as those mediated exclusively by MLCK or PAK.
• Does not replace optimized culture or differentiation protocols for stem cells; it enhances viability but is not a universal supplement.
• Concentration-dependent effects: concentrations >10 µM may induce cytotoxicity in sensitive cell types (see Q&A).

Workflow Integration & Parameters

Y-27632 dihydrochloride (SKU A3008, APExBIO) is supplied as a solid and should be stored desiccated at 4°C or below. For stock preparation, dissolve in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL); gentle warming (37°C) or ultrasound can accelerate dissolution. Stock solutions are stable for several months at <-20°C, but repeated freeze-thaw cycles should be minimized. In routine cell culture, typical working concentrations range from 1–10 µM, depending on cell type and endpoint. Y-27632 is compatible with a wide array of in vitro models, including epithelial, neuronal, and stem cell systems. For advanced troubleshooting and protocol optimization, see this practical guide, which focuses on real-world assay challenges and how Y-27632 dihydrochloride (A3008) addresses them—this article expands by including additional benchmarks and references.

For readers seeking a technical deep dive into workflow enhancements and advanced applications, this review details troubleshooting strategies; here, we provide a comparative perspective anchored in recent primary literature.

Conclusion & Outlook

Y-27632 dihydrochloride is a gold-standard, highly selective ROCK1/2 inhibitor, indispensable for cytoskeletal, stem cell, and cancer research. Its robust activity profile, validated selectivity, and reliable solubility/storage parameters enable reproducible and interpretable results in diverse experimental systems. Researchers are encouraged to source the compound from APExBIO (product page) for quality assurance and comprehensive support. Ongoing studies are expanding its application to organ-on-chip, neuro-epithelial, and regenerative models—future benchmarks will further define optimal conditions and new limitations.